Synthesis of the potent antiglaucoma agent, travoprost

Organic Process Research and Development

Volumn 6, Issue 2, 2002, Pages 138-145

  Boulton, Lee T ^a   Brick, Dean ^a   Fox, Martin E ^a   Jackson, Mark ^a   Lennon, Ian C ^a   McCague, Raymond ^a   Parkin, Nicholas ^a   Rhodes, Darren ^a   Ruecroft, Graham ^a  

^a Chirotech Technology Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 IODO 4 (3 TRIFLUOROMETHYLPHENOXY) 3 TERT BUTYLDIMETHYLSILYLOXY 1 BUTENE; 3 HYDROXYBENZOTRIFLUORIDE; 3 TERT BUTYLDIMETHYLSILYLOXYTRICYCLO[3.2.0.0 2,7 ]HEPTAN 6 ONE; 7 [4 (3 TRIFLUOROMETHYLPHENOXY) 3 TERT BUTYLDIMETHYLSILYLOXY 1 BUTENYL] 5 TERT BUTYLDIMETHYLSILYLOXYBICYCLO[2.2.1]HEPTAN 2 ONE; 8 [4 (3 TRIFLUOROMETHYLPHENOXY) 3 TERT BUTYLDIMETHYLSILYL 1 BUTENYL] 6 TERT BUTYLDIMETHYLSILOXY 2 OXABICYCLO[3.2.1]OCTAN 3 ONE; ANTIGLAUCOMA AGENT; FLUORIDE; IODINE DERIVATIVE; KETONE DERIVATIVE; LACTONE; PROSTANOID; TRAVOPROST; UNCLASSIFIED DRUG; VINYL DERIVATIVE;

ARTICLE; CHROMATOGRAPHY; DRUG SYNTHESIS; ENANTIOMER; ESTERIFICATION; OXIDATION; PURIFICATION; REDUCTION; STEREOCHEMISTRY;

EID: 0036306488     PISSN: 10836160     EISSN: None     Source Type: Journal    
DOI: 10.1021/op010097p     Document Type: Article

References (30)